Eric Sauer Takes the Helm at Armorgenix to Propel Natural Health Innovations

In an exciting development for natural health and pharmaceutical industries, Armorgenix, a subsidiary of Buscar Company (OTC: CGLD), recently announced the appointment of Eric Sauer, RPh, DHPh, as the new Chief Operating Officer. This move represents a significant step in the company's growth and expansion in its commitment to developing innovative health solutions.

Background on Armorgenix and Buscar Company

Armorgenix specializes in creating enzyme-based therapies, detoxification methods, and natural remedies that align with the growing consumer demand for sustainable and health-focused products. With Buscar Company acquiring a controlling stake of 70% in Armorgenix in June 2025, the collaboration aims to enhance product offerings that cater to both health and environmental needs.

Eric Sauer's vast experience—over 40 years in pharmacy, naturopathy, and holistic medicine—positions him as the perfect leader for this imperative role. Under Sauer's leadership, Armorgenix will focus on vital product lines, including its well-known DetoxShield and innovative antiviral therapies, all aimed at tackling global health challenges effectively.

The Vision for Armorgenix

Sauer's appointment is timely given the current landscape of the pharmaceutical market, projected to reach $854.83 billion by 2025. The strategic direction he brings will be central to expanding Armorgenix’s manufacturing capabilities, including new facilities planned for Texas and developing a Wyoming-based corporation focused on intellectual property management. These expansions are designed to optimize operations and drive market entry in the United States for enzyme-based and detoxification products.

As COO, Sauer will oversee daily operations and product development, ensuring Armorgenix’s offerings are both scientifically validated and user-friendly. His extensive background in medication safety and alternative therapies complements the clinical focus that Armorgenix strives for.

Contributions and Recognition

Sauer began his career in 1983 after receiving his pharmacy license in New Jersey. Soon, he recognized the limitations of conventional medicine and transitioned towards naturopathy, which led him to open The Natural Pharmacy and The Natural Apothecary Shoppe, renowned for their compounding practices that cater to individual health needs. He has spent more than two decades specializing in enzyme therapy with numerous certifications in homeopathy and clinical nutrition.

His commitment to the field of natural medicine was recognized in 2008 when he received the Order of Excellence from the World Organization of Natural Medicine. This accolade highlights his dedication and global contributions to advancing natural health, making him a prominent figure in the industry.

A Forward-Thinking Approach to Health

In his new role, Sauer emphasized the importance of blending traditional and holistic health strategies. He expressed his excitement about fostering product development that aligns with these principles while maintaining a steadfast focus on client safety. His involvement will also extend to community outreach and education, where he plans to conduct seminars on critical health topics such as natural hormone therapy and autism.

Alexander Dekhtyar, CEO of Buscar Company, highlighted Sauer’s unique qualifications, stating, “His blend of traditional pharmaceutical knowledge and holistic expertise makes him an ideal leader for Armorgenix at this transformative stage.” Dekhtyar also expressed confidence that Sauer’s insights will enhance their operations in enzyme therapy, clinical nutrition, and antiviral solutions, seamlessly integrating with Buscar’s diversified asset base.

Leveraging Synergies Across Holdings

Armorgenix joins a diverse portfolio under Buscar Company, which includes Eon Discovery Inc., focused on gold mining, and Terramer Inc., a leader in hemp-based biodegradable plastics. The strategic interplay between these subsidiaries is poised to amplify Buscar's presence across various sectors, pushing the boundaries of environmental sustainability and public health.

As the demand for comprehensive and integrative health solutions grows, Armorgenix stands at the forefront, readily prepared to innovate and expand under Sauer’s experienced guidance. The company is well-positioned to meet the evolving needs of health-conscious consumers and the pharmaceutical market at large.

Conclusion

With Eric Sauer at the helm, Armorgenix is set to enhance its offerings and expand its market reach significantly. The company's focus on natural health solutions not only addresses public health challenges but also aligns with a broader mission of environmental sustainability, ultimately aiming to create a healthier future.